Market Research Logo

China Pharmaceuticals and Healthcare Report Q2 2015


Attention: There is an updated edition available for this report.

China Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Pharmaceutical sales in China will continue to grow robustly - boosted by the improvement inhealthcare access, liberalisation of the industry as well as an epidemiological transition towards chronicdiseases. This will present strong revenue earning opportunities for both domestic and multinationalpharmaceutical companies. However, downside risks to this upbeat outlook remain as the government willface pressures to contain medicine costs.

Headline Expenditure Projections

Pharmaceuticals: CNY608.45bn (USD98.75bn) in 2014 to CNY686.69bn (USD110.26bn) by 2015;+12.9% in local currency terms and +11.7% in USD terms.

Healthcare: CNY3,729.07bn (USD605.22bn) in 2014 to CNY4,276.73bn (USD686.72bn) in 2015;+14.7% in local currency and +13.5% in USD terms.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (China 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (China 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (China 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (China 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (China 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (China 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (China 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (China 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (China 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (China 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Activity
Labour Market The Chief Barometer
Zhou Rumours Add New Wrinkle To Reform Story
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
China Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In China
Healthcare Sector
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Research And Development
Table: Selected List Of MNC With R&D Bases In China
Table: Selected List Of Collaboration In R&D Operations In China
Clinical Trials
Biotechnology Sector
Regulatory Development
Regulatory Regime
Table: Important China GMP Deadlines
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Competitive Landscape
Table: Companies Represented by RDPAC
Table: Top 20 China / Hong Kong-Based Pharmaceutical Companies According To Market Capitalisation
Pharmaceutical Wholesale
Recent Developments
Traditional Chinese Medicine
Company Profile
AstraZeneca
Bayer
China Shijiazhuang Pharmaceutical Group
Eli Lilly
GlaxoSmithKline
North China Pharmaceutical Corporation
Novartis
Merck & Co
Merck KGaA
Pfizer
Roche
Sanofi
Shanghai Pharmaceutical
Sinopharm
Demographic Forecast
Table: Population Headline Indicators (China 1990-2025)
Table: Key Population Ratios (China 1990-2025)
Table: Urban/Rural Population & Life Expectancy (China 1990-2025)
Table: Population By Age Group (China 1990-2025)
Table: Population By Age Group % (China 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report